彭布罗利珠单抗
医学
肿瘤科
内科学
药品
生物标志物
癌症
药物反应
药理学
遗传学
生物
免疫疗法
作者
Birgit S. Geurts,Laurien J. Zeverijn,Lindsay V.M. Leek,Jade M. van Berge Henegouwen,Louisa R. Hoes,Hanneke van der Wijngaart,Vincent van der Noort,Joris van de Haar,Annemiek van Ommen-Nijhof,Marleen Kok,Paul Roepman,Anne M.L. Jansen,Wendy W.J. de Leng,Maja J.A. de Jonge,Ann Hoeben,Carla M.L. van Herpen,Hans M. Westgeest,Lodewyk F.A. Wessels,Henk M.W. Verheul,Hans Gelderblom
标识
DOI：10.1158/1078-0432.ccr-24-0011
摘要
To evaluate the efficacy of pembrolizumab across multiple cancer types harboring different levels of whole-genome sequencing-based tumor mutational load (TML; total of nonsynonymous mutations across the genome) in patients included in the Drug Rediscovery Protocol (NCT02925234).
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
OsamaKareem
GingerF
lalala
memory
无极微光
Moonpie
arniu2008
XQQDD
iNk
风清扬
Criminology34
仰望喀纳斯的星空
小小
小安
didiwang
chandangfo
乐空思
xiaofei
vivideng
星禾吾
皖公网安备34019202002308
